Whalen Kathleen M 4
4 · HCA Healthcare, Inc. · Filed Feb 7, 2024
Insider Transaction Report
Form 4
Whalen Kathleen M
SVP & Chief Ethics Officer
Transactions
- Exercise/Conversion
Stock Appreciation Right
2024-02-05−4,040→ 0 totalExercise: $81.96Exp: 2027-02-01→ Common Stock (4,040 underlying) - Exercise/Conversion
Stock Appreciation Right
2024-02-05−2,000→ 3,040 totalExercise: $101.16Exp: 2028-01-31→ Common Stock (2,000 underlying) - Tax Payment
Common Stock
2024-02-05$310.62/sh−4,288$1,331,939→ 14,512 total - Exercise/Conversion
Stock Appreciation Right
2024-02-05−2,510→ 0 totalExercise: $69.58Exp: 2026-01-29→ Common Stock (2,510 underlying) - Exercise/Conversion
Common Stock
2024-02-05$69.58/sh+2,510$174,646→ 12,760 total - Exercise/Conversion
Common Stock
2024-02-05$81.96/sh+4,040$331,118→ 16,800 total - Exercise/Conversion
Common Stock
2024-02-05$101.16/sh+2,000$202,320→ 18,800 total
Footnotes (3)
- [F1]The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
- [F2]The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
- [F3]The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.